Impact of Positive Peritoneal Cytology on Endometrial Cancer Prognosis
Author Information
Author(s): Tebeu P-M, Popowski Y, Verkooijen H M, Bouchardy C, Ludicke F, Usel M, Major A L
Primary Institution: Fondation pour Recherches Médicales, University of Geneva, Switzerland
Hypothesis
Does positive peritoneal cytology influence the prognosis of early-stage endometrial cancer?
Conclusion
Positive peritoneal cytology does not affect the prognosis of early-stage endometrial cancer patients.
Supporting Evidence
- Patients with cytological stage IIIA had similar survival rates to those with stage I endometrial cancer.
- Histological stage IIIA patients had a significantly worse survival rate compared to stage I patients.
- The study included a comprehensive analysis of various prognostic factors.
Takeaway
This study found that having positive peritoneal cytology doesn't make women with early-stage endometrial cancer any more likely to have bad outcomes than those without it.
Methodology
The study analyzed data from a population-based cancer registry and included women diagnosed with endometrial cancer, comparing survival rates based on peritoneal cytology results.
Potential Biases
Potential bias due to the exclusion of patients with cervical involvement and the limited number of patients in certain subgroups.
Limitations
The study had a relatively low statistical power due to the limited number of patients with cytological and histological stage IIIA endometrial cancer.
Participant Demographics
Women diagnosed with endometrial cancer between 1980 and 1996 in the Swiss canton of Geneva.
Statistical Information
P-Value
p<0.001
Confidence Interval
(4.8–22.7)
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website